Related Experiment Video
Updated: Jun 2, 2026

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression
P Scott Pine1, Barry A Rosenzweig, Karol L Thompson
1Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993 USA.
BMC Biotechnology
|April 14, 2011
Summary
New ratiometric controls improve DNA microarray assay performance for molecular biomarker discovery. These controls benchmark diagnostic utility and reliable measurement ranges, enhancing clinical applications of gene expression data.
Area of Science:
- Molecular biology
- Genomics
- Biomarker discovery
Background:
- mRNA transcript-based molecular biomarkers are crucial for disease diagnosis and treatment.
- DNA microarrays are key for developing gene expression classifiers for clinical outcomes.
- Current microarray assays have limitations in dynamic range and fold change detection, necessitating improved assay controls.
Purpose of the Study:
- To develop and validate ratiometric controls for benchmarking DNA microarray assay performance.
- To assess diagnostic performance and reliable measurement ranges using these novel controls.
- To demonstrate process improvements in microarray assays for clinical utility.
Main Methods:
- Prepared ratiometric controls from commercial human RNA with distinct expression profiles, mixed in defined ratios.
- Processed samples using six target labeling protocols and generated replicate datasets on high-density gene expression microarrays.
- Utilized receiver operating characteristic plots and log(2) ratio deviation plots to measure diagnostic performance and reliable dynamic range.
Main Results:
- Statistically significant differences in diagnostic performance were observed between standardized and alternative target generation methods.
- Assay performance, measured by the reliable range of comparative measurement, improved by adjusting hybridization conditions for a commercial kit.
- Ratiometric controls enabled the derivation of reliable dynamic range and diagnostic performance metrics.
Conclusions:
- Process improvements in microarray assay performance were demonstrated using commercially available materials and validated metrics.
- The developed methods provide benchmark values for optimizing protocols and laboratory proficiency in clinical settings.
- These controls offer advantages over limited external controls or reference set correlations for assay validation.

